Neurizon Therapeutics Makes Three Executive Appointments; Shares Up 15%

MT NewswiresApr 17 01:25 ET

Neurizon Therapeutics Completes Study of Drug Candidate on Mouse Motor Neuron Cell Line

MT NewswiresApr 4 02:39 ET

Neurizon Finds Positive Results for Lead Drug in 3D Brain Model Study

The Market HeraldMar 31 20:53 ET

ASX Biggest Gainers

MT NewswiresMar 27 22:01 ET

Neurizon Therapeutics Moves to Lift FDA Suspension on NUZ-001 Drug Candidate With Two Studies; Shares Fall 5%

MT NewswiresMar 16 23:30 ET

Investing in Neurizon Therapeutics (ASX:NUZ) Five Years Ago Would Have Delivered You a 54% Gain

Yahoo FinanceFeb 18 15:19 ET